A focused collection of 24 calculators, scores, and clinical references.
ADHERE Renal Subscore: Explanation and Clinical Context The ADHERE Renal Subscore is part of the ADHERE risk model, developed to estimate in-hospital mortality risk for patients admitted with acute decompensated heart failure (ADHF). It incorporates renal function parameters, specifically serum creatinine and blood urea nitrogen (BUN) levels, to assess the severity of renal impairment. Higher levels of creatinine and
AKI–KDIGO Stage Correlation with Heart Failure Mortality: Explanation and Clinical Context Acute Kidney Injury (AKI) defined by KDIGO criteria is strongly associated with increased mortality in patients hospitalized with heart failure. Stage 1 AKI is associated with a modest increase in in-hospital and short-term mortality, whereas Stage 2 and Stage 3 AKI significantly elevate the risk of death. Patients with severe
Blood Urea Nitrogen/Creatinine (BUN/Cr) Ratio: Explanation and Clinical Context The BUN/Cr ratio is a commonly used biochemical marker to assess the relative elevation of blood urea nitrogen compared to serum creatinine. It is widely applied in the context of acute kidney injury (AKI), volume depletion, and other renal and systemic conditions. A BUN/Cr ratio <10 is generally considered low risk, indicating a low like
CA125 Congestive Cardiorenal Score (CCRS): Explanation and Clinical Context The CA125 Congestive Cardiorenal Score (CCRS) is a validated risk assessment tool designed to predict adverse cardiorenal events in patients with heart failure. It integrates clinical parameters including age, NYHA functional class, serum creatinine levels, and CA125 levels to estimate the risk of worsening cardiorenal syndrome and overall pr
CARRESS-HF Renal Decompensation Score: Explanation and Clinical Context The CARRESS-HF Renal Decompensation Score is a clinical tool designed to predict the risk of worsening renal function in patients hospitalized for acute decompensated heart failure. It incorporates patient age, baseline renal function (serum creatinine, BUN), systolic blood pressure, and urine output to stratify risk. This score helps clinicians
CHARM Renal Subgroup Score: Explanation and Clinical Context The CHARM Renal Subgroup Score was developed from the CHARM trials to assess prognosis in heart failure patients with renal dysfunction. It incorporates age, renal function (serum creatinine), NYHA class, and comorbidities such as diabetes, hypertension, and prior myocardial infarction. Higher scores are associated with increased risk of cardiovascular deat
Cystatin C-Based Cardiovascular Mortality Index: Explanation and Clinical Context The Cystatin C-Based Cardiovascular Mortality Index utilizes serum cystatin C levels to estimate glomerular filtration rate (GFR), providing a more accurate assessment of renal function compared to creatinine-based methods. Elevated cystatin C levels have been associated with increased risks of cardiovascular mortality, independent of t
Dialysis Need Prediction Score (HF + AKI): Explanation and Clinical Context This prediction model estimates the likelihood of requiring dialysis in patients with acute heart failure complicated by acute kidney injury. It incorporates clinical variables such as age, serum creatinine, heart rate, blood urea nitrogen, and albuminuria. The model has been validated for its accuracy and reliability in predicting dialysis n
Diuretic Efficiency Index (DEI): Explanation and Clinical Context Diuretic Efficiency Index (DEI) quantifies the effectiveness of loop diuretics by relating the change in patient weight (ΔWeight, representing fluid loss) to the administered diuretic dose (furosemide equivalent in mg). It is primarily used in patients with acute decompensated heart failure to assess diuretic response and guide therapy adjustments. A h
ESC Cardiorenal Decision Pathway: Explanation and Clinical Context The ESC Cardiorenal Decision Pathway integrates key clinical parameters to assess the risk of adverse outcomes in patients with concurrent cardiovascular and renal conditions. This pathway aids clinicians in stratifying patients into risk tiers, facilitating tailored management strategies. The parameters considered include age, estimated glomerular fi
ESC-HF Renal Dysfunction Algorithm: Explanation and Clinical Context The ESC-HF Renal Dysfunction Algorithm is designed to stratify the risk of renal impairment in patients with heart failure. It incorporates age, estimated glomerular filtration rate (eGFR), NYHA functional class, and comorbidities including diabetes mellitus and hypertension. Risk scoring helps clinicians identify patients at low, intermediate, or h
The audited source currently returns an empty page. This catalog entry is retained for coverage and monitoring, but no clinical content or calculation is asserted.
Furosemide Response Index (FRI): Explanation and Clinical Context The Furosemide Response Index (FRI) is a clinical tool designed to quantify the early response of patients with acute decompensated heart failure (ADHF) to intravenous loop diuretics. It is calculated as the urine output (mL/hour) divided by the administered loop diuretic dose (mg/day). FRI allows clinicians to identify patients with poor diuretic resp
GFR Decline Rate (%/year): Explanation and Clinical Context The GFR Decline Rate quantifies the annualized percentage change in estimated glomerular filtration rate (eGFR) over time. It is calculated as: ((Follow-up eGFR – Baseline eGFR) / Baseline eGFR) / Time interval in years × 100. This metric is crucial for identifying patients at risk of progressive chronic kidney disease (CKD). A decline rate >5% per year is t
Inotrope-Induced Renal Improvement (IRI) Index: Explanation and Clinical Context The IRI Index is a predictive tool designed to assess renal function improvement in patients receiving inotropic therapy, particularly in the context of acute decompensated heart failure or cardiogenic shock. It integrates the change in serum creatinine over the first 48 hours of therapy (ΔCreatinine) with the cardiac index achieved duri
KDIGO Cardiovascular Comorbidity Risk Stratification: Explanation and Clinical Context The KDIGO cardiovascular comorbidity risk stratification framework integrates albuminuria and estimated glomerular filtration rate (eGFR) to assess cardiovascular risk in patients with chronic kidney disease (CKD). This approach emphasizes the importance of kidney function and albuminuria as significant factors influencing cardiova
NGAL Predictive Model: Explanation and Clinical Context The NGAL predictive model estimates the risk of acute kidney injury (AKI) based on serum NGAL levels, age, and serum creatinine. Elevated NGAL levels are indicative of kidney injury, and when combined with clinical parameters, they enhance the accuracy of AKI risk stratification.
RAAS Activation Index (Plasma Renin Activity): Explanation and Clinical Context The RAAS Activation Index reflects the activity of the renin–angiotensin–aldosterone system (RAAS), which plays a crucial role in regulating blood pressure, sodium, and fluid balance. Plasma Renin Activity (PRA) measures the enzymatic activity of renin, expressed in ng/mL/h, which indicates how strongly the RAAS system is activated. Low P
Renal Angina Index (RAI): Explanation and Clinical Context The Renal Angina Index (RAI) is a validated tool to predict the development of severe acute kidney injury (AKI) in critically ill patients, especially pediatric ICU patients. It is calculated by multiplying a Risk Score (based on underlying condition severity) with an Injury Score (based on early signs such as fluid overload or rise in creatinine). RAI > 8 in
Renal Recovery Probability (after HF hospitalization): Explanation and Clinical Context The Renal Recovery Probability (RRP) score is a clinical tool developed to predict the likelihood of kidney function recovery within 90 days and 12 months after dialysis initiation in patients with end-stage kidney disease due to acute kidney injury (AKI). It incorporates factors such as age, sex, body mass index (BMI), hemoglobin
Renal Resistive Index (RRI) by Doppler Ultrasound: Explanation and Clinical Context The Renal Resistive Index (RRI) is a non-invasive Doppler ultrasound parameter used to evaluate renal arterial resistance and kidney perfusion. It is calculated using the formula: RRI = (PSV - EDV) / PSV, where PSV is the peak systolic velocity and EDV is the end diastolic velocity of intrarenal arteries. Normal RRI values range betwe
Spot Urine Sodium Response Score: Explanation and Clinical Context The Spot Urine Sodium Response Score (SUNSS) is a clinical tool designed to predict the likelihood of poor diuretic response in patients with acute decompensated heart failure (ADHF). It incorporates key variables that influence natriuretic response: age, systolic blood pressure, serum sodium, and spot urine sodium. Lower urine sodium indicates reduce
Unloading Diuretic Response Index (UDRI): Explanation and Clinical Context The Unloading Diuretic Response Index (UDRI) is a clinical tool designed to quantify the effectiveness of loop diuretics in acute decompensated heart failure by adjusting for body weight and administered diuretic dose. It is calculated as the net fluid loss normalized to body weight and standard loop diuretic dose (usually per 40 mg IV furosem
Worsening Renal Function (WRF) Index in Heart Failure: Explanation and Clinical Context The WRF Index predicts the risk of acute kidney injury or worsening renal function in patients hospitalized with acute decompensated heart failure. It uses clinical variables such as age, baseline serum creatinine, systolic blood pressure, and heart rate at admission. Higher predicted probabilities indicate a higher likelihood of